Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Victor H. Jimenez- Zepeda
Observed name:
Victor H. Jimenez-Zepeda
Institutions:
Alberta Health Services,
University of Calgary,
Weill Cornell Medicine
Observed institutions:
Alberta Health Services,
University of Calgary,
Weill Cornell Medicine
ORCID:
0000-0002-9294-9437
Observed ORCID:
0000-0002-9294-9437
OpenAlex ID:
A5128701765
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials
2026
·
Ashutosh D. Wechalekar
, Angela Dispenzieri
, et al.
·
Journal of Clinical Oncology
·
2
Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials
2026
·
Ashutosh D. Wechalekar
, Angela Dispenzieri
, et al.
·
Journal of Clinical Oncology
·
1
Phase 3 randomized trial to evaluate the impact of anselamimab on all-cause mortality in κ light-chain amyloidosis.
2026
·
Ashutosh D. Wechalekar
, Angela Dispenzieri
, et al.
·
Journal of Clinical Oncology
Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian report
2026
·
Martha L. Louzada
, Donna Reece
, et al.
·
Blood Neoplasia
Show more works
View as search
Works count:
4
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type
